Non‐canonical cMet regulation by vimentin mediates Plk1 inhibitor–induced apoptosis
Abstract To address the need for improved systemic therapy for non–small‐cell lung cancer (NSCLC), we previously demonstrated that mesenchymal NSCLC was sensitive to polo‐like kinase (Plk1) inhibitors, but the mechanisms of resistance in epithelial NSCLC remain unknown. Here, we show that cMet was d...
Gardado en:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Nature
2019-04-01
|
| Series: | EMBO Molecular Medicine |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.15252/emmm.201809960 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|